Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 3/20 | 0.55 |
| ▸ | ACHE | P22303 | 2/20 | 0.55 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.49 |
| ▸ | HTR1A | P08908 | 1/20 | 0.46 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.44 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.43 |
| ▸ | NT5E | P21589 | 1/20 | 0.42 |
| ▸ | SSTR1 | P30872 | 1/20 | 0.41 |
| ▸ | SSTR2 | P30874 | 1/20 | 0.41 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.41 |
| ▸ | SSTR3 | P32745 | 1/20 | 0.41 |
| ▸ | SSTR5 | P35346 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | TACR2 | P21452 | 1/20 | 0.40 |
| ▸ | GJB2 | P29033 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26428931 | 1.00 | BCHE (0.55) | BCHEACHESLC6A2HTR1APDE4D | |
| SCHEMBL19891607 | 1.00 | BCHE (0.55) | BCHEACHESLC6A2HTR1APDE4D | |
| SCHEMBL18822660 | 1.00 | BCHE (0.55) | BCHEACHESLC6A2HTR1APDE4D | |
| SCHEMBL20140085 | 1.00 | BCHE (0.55) | BCHEACHESLC6A2HTR1APDE4D | |
| SCHEMBL19891743 | 1.00 | BCHE (0.55) | BCHEACHESLC6A2HTR1APDE4D | |
| SCHEMBL18485164 | 1.00 | BCHE (0.55) | BCHEACHESLC6A2HTR1APDE4D | |
| SCHEMBL19380966 | 0.97 | BCHE (0.55) | BCHEACHESLC6A2HTR1APDE4D | |
| SCHEMBL18640660 | 0.97 | BCHE (0.55) | BCHEACHESLC6A2HTR1APDE4D | |
| SCHEMBL22316285 | 0.97 | BCHE (0.55) | BCHEACHESLC6A2HTR1APDE4D | |
| SCHEMBL29937530 | 0.97 | BCHE (0.55) | BCHEACHESLC6A2HTR1APDE4D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023011597-A1 | LIGAND CONJUGATES FOR DELIVERY OF THERAPEUTICALLY ACTIVE AGENTS | Hepagene Therapeutics (HK) Limited (CN) | 2023-02-09 | — | — | WO | disclosed |
| US-20220127239-A1 | GLYCOSYL DONOR, PREPARATION METHOD THEREFOR, AND USE THEREOF | SICHUAN UNIVERSITY (CN) | 2022-04-28 | — | — | US | disclosed |
| WO-2021013155-A1 | NOVEL GLYCOSYL DONOR, PREPARATION METHOD THEREFOR, AND USE THEREOF | 四川大学 | 2021-01-28 | — | — | WO | disclosed |
| EP-2714032-B1 | NOVEL DIPHENYLMETHANE DERIVATIVES AS SGLT2 INHIBITORS | GREEN CROSS CORP (KR) | 2019-01-16 | — | — | EP | disclosed |
| WO-2018035416-A1 | REAGENTS AND METHODS FOR GLYCOSYLATION | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2018-02-22 | — | — | WO | disclosed |
| EP-2714636-B9 | FAMILY OF ARYL, HETEROARYL, O-ARYL AND O-HETEROARYL CARBASUGARS | TFCHEM (FR) | 2017-03-22 | — | — | EP | disclosed |
| EP-2163555-A1 | New pyrazole derivatives and diabetic medicine containing them | Ajinomoto Co., Inc. (JP) | 2010-03-17 | — | — | EP | disclosed |
| EP-1338603-B1 | NOVEL PYRAZOLE DERIVATIVES AND DIABETES REMEDIES CONTAINING THE SAME | AJINOMOTO KK (JP) | 2010-01-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220127239-A1 | GLYCOSYL DONOR, PREPARATION METHOD THEREFOR, AND USE THEREOF | UGGT1, ALG8, FUT6 | BCHE 1099/4885ACHE 2611/4885SLC6A2 2076/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.